Cilostazol-combo antiplatelet therapy reduced risk for recurrent stroke

https://s3.amazonaws.com/cms.ipressroom.com/67/files/20191/5c5b9b232cfac2726285f03a_Kazunori Toyoda M.D. Ph.D./Kazunori Toyoda M.D. Ph.D._thmb.jpg

Study Highlight: The long-term combination of cilostazol with aspirin or clopidogrel resulted in fewer recurrent strokes than with aspirin or clopidogrel alone in high-risk patients.